Theriva Biologics, Inc. (TOVX) Operating income 2016–2025
Theriva Biologics, Inc. (TOVX) annual operating income history from SEC filings — each fiscal year as reported.
-$24.1MFY2025 · since FY2016: -$39.3M → -$24.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.1M | +8.7% |
| FY2024 | -$26.3M | -22.9% |
| FY2023 | -$21.4M | +0.7% |
| FY2022 | -$21.6M | -51.2% |
| FY2021 | -$14.3M | -40.5% |
| FY2020 | -$10.2M | +35.1% |
| FY2019 | -$15.7M | +10.9% |
| FY2018 | -$17.6M | +33.1% |
| FY2017 | -$26.3M | +33.1% |
| FY2016 | -$39.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice